SomaLogic is developing breakthrough clinical diagnostics based on protein signatures for a variety of rare and common diseases. We focus on applying excellent and rigorous science to the discovery and development of potential new diagnostic tests, with the goal of marketing first-in-class and/or best-in-class diagnostic products.
Our current diagnostics research and development pipeline currently targets ~ 50 conditions (diseases, states, nutrition, wellness, etc.), including the following:
Oncology
- Non-small Cell Lung cancer
- Pancreatic cancer
- Ovarian cancer
- Renal cell carcinoma
- Mesothelioma
- Melanoma
Neurology
- Amyotrophic lateral sclerosis (ALS)
- Multiple sclerosis
- Alzheimer's disease
- Parkinson's Disease
Cardiovascular and Metabolic Disease
- Cardiovascular event prediction
- Coronary artery disease
- Chronic kidney disease/renal failure
- Obesity
- Fatty liver/liver fibrosis
Other Diseases and Conditions
- Pre-term labor
- Infectious microbial agent detection and host response
- Acute lung injury
- Sepsis
- Rheumatoid arthritis